Gemzell-Danielsson K

No ORCID on file · 33 papers in corpus · active 2009-2026

Study types

  • article 9
  • other 4
  • preprint 4
  • review 3
  • letter 1

Condition tags

  • endometriosis 18
  • infertility 6
  • adenomyosis 5
  • endometrioma 2
  • chronic_pelvic_pain 1
  • dysmenorrhea 1
  • dyspareunia 1
2026
International journal of cancer ·doi:10.1002/ijc.70354

The DNA methylation-based WID-qEC test, applied to cervico-vaginal samples, has been validated for the accurate detection of endometrial and cervical cancers. However, a small proportion of women test positive despite the absence of these c…

preprint 2025
·doi:10.20944/preprints202501.0736.v1

Background/Objectives: Endometriosis has a marked impact on fertility, although the mechanisms behind this relationship remain poorly understood, particularly in cases without significant anatomical distortions or in the context of ovarian …

other 2025
medRxiv : the preprint server for health sciences ·doi:10.1101/2025.10.22.25338556

Endometriosis is a common chronic gynecological disorder with complex and poorly understood etiology and no definitive cure. Beyond pain and infertility, affected individuals frequently experience psychiatric comorbidities, often attributed…

preprint 2024
·doi:10.1101/2024.02.27.580606

Abstract Current therapeutics of endometriosis are limited to hormonal action on endometriotic lesions to disrupt their growth. Based on the recent findings of the high utilization of glycolysis over oxidative metabolism (Warburg-like effec…

other 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1465393

BACKGROUND: Endometriosis is characterized by the ectopic growth of endometrial-like cells, causing chronic pelvic pain, adhesions and impaired fertility in women of reproductive age. Usually, these lesions grow in the peritoneal cavity in …

2024
BMJ open ·doi:10.1136/bmjopen-2024-090402

BackgroundMifepristone is a selective progesterone receptor modulator with decades of data demonstrating its potential as a highly effective emergency as well as non-emergency contraceptive. Despite considerable evidence pointing to the pot…

article 2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1026168

OBJECTIVE: Bromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown. The purpose of th…

preprint 2023
·doi:10.20944/preprints202306.0024.v1

Our aim was to compare the inter-rater agreement of Transvaginal ultrasonography (TVS) with Magnetic Resonance Imaging (MRI) regarding diagnosing adenomyosis and for various predefined imaging features of adenomyosis in the same set of wome…

2023
Breast cancer research : BCR ·doi:10.1186/s13058-023-01661-0

Many factors, including reproductive hormones, have been linked to a woman's risk of developing breast cancer (BC). We reviewed the literature regarding the relationship between ovulatory menstrual cycles (MCs) and BC risk. Physiological va…

2022
Genome medicine ·doi:10.1186/s13073-022-01063-5

BackgroundBreast cancer is a leading cause of death in premenopausal women. Progesterone drives expansion of luminal progenitor cells, leading to the development of poor-prognostic breast cancers. However, it is not known if antagonising pr…

2022
The Lancet regional health. Europe ·doi:10.1016/j.lanepe.2022.100470

BackgroundEvidence on a possible association between newer hormonal contraceptives (HC) and risk of breast cancer remains inconclusive, especially as concerns progestogen-only methods.MethodsIn this nationwide prospective cohort study, all …

2022
BMJ open ·doi:10.1136/bmjopen-2021-052192

IntroductionMedical treatment is a less invasive alternative to surgical management of missed miscarriage. Studies have shown that pretreatment with mifepristone can increase the complete abortion rate in management of first-trimester misse…

2021
Advances in therapy ·doi:10.1007/s12325-020-01564-y

IntroductionUp to one-third of women of reproductive age experience heavy menstrual bleeding (HMB). HMB can give rise to iron deficiency (ID) and, in severe cases, iron-deficiency anemia (IDA).AimTo review current guidelines for the managem…

2021
Contraception ·doi:10.1016/j.contraception.2021.07.004

ObjectiveTo develop a minimum data set, known as a core outcome set, for future abortion randomized controlled trials.Study designWe extracted outcomes from quantitative and qualitative systematic reviews of abortion studies to assess using…

2020
Stem cell research & therapy ·doi:10.1186/s13287-019-1496-2

BackgroundIn Asherman's syndrome (AS), intrauterine scarring and fibrotic adhesions lead to menstrual disorders, pregnancy loss, or infertility. A few clinical trials have piloted cell therapy to overcome AS. Understanding the role of the s…

preprint 2020
·doi:10.1101/2020.07.17.203844

Abstract The endometrium undergoes regular regeneration and stromal proliferation as part of the normal menstrual cycle. To better understand cellular interactions driving the mechanisms in endometrial regeneration we employed single-cell R…

article 2020
Human Reproduction ·doi:10.1093/humrep/deaa164

STUDY QUESTION: What is the physiological role of transforming growth factor-beta (TGF-β1) and syndecans (SDC1, SDC4) in endometriotic cells in women with endometriosis? SUMMARY ANSWER: We observed an abnormal, pro-invasive phenotype in a s…

article 2020
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.08.040

ObjectiveVaginal bromocriptine significantly reduces heavy menstrual bleeding and pain in women with diffuse adenomyosis. The aim of this pilot study was to evaluate whether imaging findings of adenomyosis, as assessed by transvaginal ultra…

review 2019
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2019.11.003

Research questionWomen with endometriosis are considered to be at higher risk of several chronic diseases, such as autoimmune disorders, gynaecological cancers, asthma/atopic diseases and cardiovascular and inflammatory bowel diseases. Coul…

other 2019
European journal of epidemiology ·doi:10.1007/s10654-018-0474-9

Some studies have suggested that infertility is a risk factor for endometrial, ovarian and breast cancer. The study aimed to create a comprehensive picture of the association between infertility and the risk of ovarian, endometrial and brea…

other 2018
Human Reproduction ·doi:10.1093/humrep/dey241

STUDY QUESTION: Is there molecular evidence for a link between endometriosis and endometriosis-associated ovarian cancers (EAOC)? STUDY ANSWER: We identified aberrant gene expression signatures associated with malignant transformation in a…

2017
Scientific reports ·doi:10.1038/s41598-017-10098-3

Previous transcriptome studies of the human endometrium have revealed hundreds of simultaneously up- and down-regulated genes that are involved in endometrial receptivity. However, the overlap between the studies is relatively small, and we…

2017
Contraception ·doi:10.1016/j.contraception.2016.12.009
letter 2017
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.13155

Endometriosis is a common disease with severe impact on quality of life but its etiology is still poorly understood and diagnosis and adequate treatment is frequently delayed. In this theme issue of AOGS we have included reviews and origina…

article 2014
Human Reproduction ·doi:10.1093/humrep/deu161

STUDY QUESTION: Does the methylation status of the promoter region of the HOXA10 gene differ in eutopic and ectopic endometrium? SUMMARY ANSWER: The eutopic endometrium in women with endometriosis is significantly more methylated when compa…